Occult axillary node metastases in breast cancer are prognostically significant: Results in 368 node negative patients with 20-year follow-up

Advances in Anatomic Pathology

Volumn 15, Issue 6, 2008, Pages 370-373

  Jaffer, Shabnam ^a   Nagi, Chandandeep ^a   Bleiweiss, Ira J ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AXILLARY LYMPH NODE; BREAST CANCER; BREAST METASTASIS; CANCER DIAGNOSIS; CANCER PATIENT; CANCER SURVIVAL; CLINICAL ARTICLE; DISEASE FREE SURVIVAL; FOLLOW UP; HUMAN; HUMAN TISSUE; LYMPH NODE BIOPSY; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MASTECTOMY; NOTE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; SENTINEL LYMPH NODE;

EID: 67649610284     PISSN: 10724109     EISSN: 15334031     Source Type: Journal    
DOI: 10.1097/PAP.0b013e31818a64e5     Document Type: Note

References (17)

1. International (Ludwig) Breast Cancer Study Group. Prognostic importance of occult axillary lymph node micrometastases from breast cancers. International (Ludwig) Breast Cancer Study Group. Lancet. 1990;335:1565-1568.
2. Cote RJ, Peterson HF, Chaiwun B, et al. Role of immunohistochemical detection of lymph-node metastases in management of breast cancer. International Breast Cancer Study Group. Lancet. 1999;354:896-900.
3. de Mascarel I, Bonichon F, Coindre JM, et al. Prognostic significance of breast cancer axillary lymph node micrometastases assessed by two special techniques: reevaluation with longer followup. Br J Cancer. 1992;66:523-527.
4. Noguchi S, Aihara T, Nakamori S, et al. The detection of breast carcinoma micrometastases in axillary lymph nodes by means of reverse transcriptase-polymerase chain reaction. Cancer. 1994;74: 1595-1600.
5. Sedmak DD, Meineke TA, Knechtges DS, et al. Prognostic significance of cytokeratin-positive breast cancer metastases. Mod Pathol. 1989;2:516-520.
6. Trojani M, de Mascarel I, Bonichon F, et al. Micrometastases to axillary lymph nodes from carcinoma of breast: detection by immunohistochemistry and prognostic significance. Br J Cancer. 1987;55:303-306.
7. Weaver D. Sentinel lymph nodes and breast carcinoma: which micrometastases are clinically significant? Am J Surg Pathol. 2003; 27:842-845.
8. Huvos AG, Hutter R, Berg JW. Significance of axillary macrometastases and micrometastases in mammary cancer. Ann Surg. 1971;173:44-46.
9. Attiyeh FF, Jensen M, Huvos AG, et al. Axillary micrometastases and macrometastases in carcinoma of the breast. Surg Gynecol Obset. 1977;144:839-842.
10. Fisher ER, Swamidoss S, Lee CH, et al. Detection and significance of occult axillary node metastases in patients with invasive breast cancer. Cancer. 1978;42:2025-2031.
11. Rosen PP, Saigo P, Weathers E, et al. Axillary micro- and macrometastases in breast cancer: prognostic significance of tumor size. Ann Surg. 1981;194:585-591.
12. Treseler P. Pathologic examination of the sentinel lymph node: what is the best method? Breast J. 2006;12:s143-s151.
13. Dowlatshahi K, Ming F, Snider C, et al. Lymph node micrometastases from breast carcinoma: reviewing the dilemma. Cancer. 1997;80:1188-1197.
14. Colleoni M, Rotmensz N, Peruzzotti G, et al. Size of breast cancer metastases in axillary lymph nodes: clinical relevance of minimal lymph node involvement. J Clin Oncol. 2005;23:1379-1389.
15. Grabau D, Jensen MB, Rank F, et al. Axillary lymph node micrometastases in invasive breast cancer: national figures on incidence and overall survival. APMIS. 2007;115:828-837.
16. Kuijt GP, Voogd AC, van de Poll-Franse LV, et al. The prognostic significance of axillary lymph-node micrometastases in breast cancer patients. Eur J Surg Oncol. 2005;31:500-505.
17. Ann Surg Oncol. 11: 568-572.